drugset / Trial / NCT00273455

Lumigan Versus Cosopt

NCT00273455

Phase 4 Completed 34 enrolled Pharmaceutical Research Network
RandomizedCrossoverDouble-blindTreatment

Summary

To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in patients insufficiently controlled on latanoprost monotherapy

Timeline

Start
2006-01
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 %
Subject Dorzolamide Small molecule 2 %
Subject Timolol Other / unclassified 0.5 %

Indications